Clinical trials: Glabellar Frown Lines

Glabellar Frown Lines

AI-09 In Subjects With Glabellar Lines, GL-101

• Completed
• Age: 20 to 70 years
• Phase 1/2
• Results posted

AI-09 In Subjects with Glabellar Lines

Trial name

NCT05565950

Testing

AI-09, Vehicle

Where

4 sites in United States

Volunteers

96 people, healthy volunteers welcome

Sponsor

Eirion Therapeutics Inc.